Overview

A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics (PK, the Measure of How the Human Body Processes a Substance) of ETX0282 When Administered Orally to Healthy Participants

Status:
Completed

Trial end date:
2019-09-11

Target enrollment:

Participant gender:

Summary

This research project is being conducted to investigate the safety, tolerability, and pharmacokinetics (PK) of a single ascending dose (SAD) and multiple ascending doses (MAD) of oral ETX0282 when administered alone and in combination with cefpodoxime proxetil in healthy adult participants.

Phase:

Phase 1

Details

Lead Sponsor:

Entasis Therapeutics

Treatments:

Cefpodoxime
Cefpodoxime proxetil
Ceftizoxime